Clinical evaluation of polymerase chain reaction reverse hybridization assay for detection and identification of human papillomavirus type 16 variants
✍ Scribed by Gloria I. Sanchez; Bernhard Kleter; Tarik Gheit; Leen-Jan van Doorn; Maurits N.C. de Koning; Silvia de Sanjosé; Laia Alemany; Xavier F. Bosch; Massimo Tommasino; Nubia Muñoz; Wim G.V. Quint
- Book ID
- 116632079
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 365 KB
- Volume
- 51
- Category
- Article
- ISSN
- 1386-6532
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Human papillomavirus type 16 (HPV-16) DNA is detected commonly in cervical carcinomas; in this study, we have determined the analytical sensitivities of Hybrid Capture, HPV-consensus PCR, and three HPV-16-specific polymerasechain reactions (PCRs) for the detection of HPV-I6 DNA. Samples investigated
## Abstract The ability to detect the presence of human pap‐illomavirus (HPV)‐DNA sequences in urine was evaluated using polymerase chain reaction (PCR). DMA was purified and extracted from urine samples, and subjected to 40 cycles of amplification using the consensus primer pair MY11 and MY09. Coa